These Nike Analysts Are No Longer Bullish; Here Are Top 5 Downgrades For Friday
Portfolio Pulse from Avi Kapoor
Several top Wall Street analysts have downgraded their ratings for Nike, Charles River Laboratories, and Infinera. Nike received downgrades from JP Morgan, Stifel, and Morgan Stanley, with price targets significantly reduced. Charles River Laboratories was downgraded by Argus Research, and Infinera was downgraded by Needham.
June 28, 2024 | 1:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Nike received multiple downgrades from JP Morgan, Stifel, and Morgan Stanley, with price targets cut to $83, $88, and $79 respectively. Despite these downgrades, Nike shares gained 0.1% to close at $94.19 on Thursday.
Multiple downgrades from top analysts and significant reductions in price targets indicate a bearish outlook for Nike in the short term. Despite a slight gain in share price, the overall sentiment is negative.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
NEUTRAL IMPACT
Argus Research downgraded Charles River Laboratories from Buy to Hold. The stock gained 0.3% to close at $207.35 on Thursday.
The downgrade from Argus Research to Hold suggests a neutral outlook for Charles River Laboratories. The slight gain in share price indicates limited immediate impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Needham downgraded Infinera Corporation from Buy to Hold. The stock rose 1.5% to close at $5.26 on Thursday.
The downgrade from Needham to Hold suggests a neutral outlook for Infinera. The increase in share price indicates that the market may have already priced in the downgrade.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70